|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
2,630,000,000 |
Market
Cap: |
406.70(B) |
Last
Volume: |
6,512,369 |
Avg
Vol: |
8,301,717 |
52
Week Range: |
$144.45 - $174.48 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
DOW JONES COMPOSITE |
|
DOW JONES INDUSTRIAL AVERAGE |
|
NYSE COMPOSITE |
|
S&P 100 |
|
S&P 500 |
|
MAJOR MARKET |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 21 |
Guru Rank Value : 20.3 |
Guru Occurances : 6 |
|
|
|
|
|
|
|
Company Profile Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of products in the health care field. Co. has three business segments: Consumer Health, which includes products focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
8,891 |
68,288 |
115,451 |
522,170 |
Total Sell Value |
$1,441,765 |
$10,723,734 |
$18,652,688 |
$88,845,171 |
Total People Sold |
1 |
2 |
5 |
10 |
Total Sell Transactions |
1 |
2 |
5 |
24 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mesquita Jorge S. |
Exec VP, WW Chair, Consumer |
|
2018-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,688 |
32,688 |
|
- |
|
Ullmann Michael H |
Exec VP, General Counsel |
|
2018-01-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
179 |
109,304 |
|
- |
|
Gorsky Alex |
Chairman, CEO |
|
2017-12-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,153 |
252,825 |
|
- |
|
Stoffels Paulus |
Exec VP, Chief Scientific Off |
|
2017-10-31 |
4 |
D |
$139.54 |
$4,847,899 |
D/D |
(34,742) |
168,400 |
|
- |
|
Stoffels Paulus |
Exec VP, Chief Scientific Off |
|
2017-10-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
75,492 |
203,142 |
|
- |
|
Perez William D |
Director |
|
2017-10-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,400 |
9,100 |
|
- |
|
Stoffels Paulus |
Exec VP, Chief Scientific Off |
|
2017-07-24 |
4 |
S |
$133.14 |
$13,672,629 |
D/D |
(102,692) |
127,650 |
|
- |
|
Stoffels Paulus |
Exec VP, Chief Scientific Off |
|
2017-07-24 |
4 |
OE |
$72.54 |
$7,449,278 |
D/D |
102,692 |
230,342 |
|
- |
|
Caruso Dominic J |
Exec VP, Finance; CFO |
|
2017-07-20 |
4 |
S |
$136.72 |
$11,291,478 |
D/D |
(82,591) |
144,102 |
|
- |
|
Caruso Dominic J |
Exec VP, Finance; CFO |
|
2017-07-20 |
4 |
OE |
$61.75 |
$5,099,994 |
D/D |
82,591 |
226,693 |
|
- |
|
Ullmann Michael H |
Exec VP, General Counsel |
|
2017-05-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
409 |
109,483 |
|
- |
|
Pruden Gary J |
Exec VP, WW Chair, Med Devices |
|
2017-02-28 |
4 |
S |
$122.21 |
$1,991,943 |
D/D |
(16,299) |
43,630 |
|
- |
|
Ullmann Michael H |
Exec VP, General Counsel |
|
2017-02-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
208 |
109,892 |
|
- |
|
Stoffels Paulus |
Exec VP, Chief Scientific Off |
|
2017-02-15 |
4 |
S |
$117.29 |
$2,580,274 |
D/D |
(22,000) |
127,650 |
|
- |
|
Duato Joaquin |
Exec VP, WW Chair, Pharma |
|
2017-02-13 |
4 |
D |
$115.67 |
$1,870,962 |
D/D |
(16,175) |
68,536 |
|
- |
|
Duato Joaquin |
Exec VP, WW Chair, Pharma |
|
2017-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
8,897 |
84,711 |
|
- |
|
Duato Joaquin |
Exec VP, WW Chair, Pharma |
|
2017-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,298 |
75,814 |
|
- |
|
Pruden Gary J |
Exec VP, WW Chair, Med Devices |
|
2017-02-13 |
4 |
D |
$115.67 |
$1,118,876 |
D/D |
(9,673) |
59,929 |
|
- |
|
Pruden Gary J |
Exec VP, WW Chair, Med Devices |
|
2017-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,197 |
69,602 |
|
- |
|
Pruden Gary J |
Exec VP, WW Chair, Med Devices |
|
2017-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,532 |
63,405 |
|
- |
|
Kapusta Ronald A |
Controller, CAO |
|
2017-02-13 |
4 |
D |
$115.67 |
$109,308 |
D/D |
(945) |
29,964 |
|
- |
|
Kapusta Ronald A |
Controller, CAO |
|
2017-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
857 |
30,909 |
|
- |
|
Kapusta Ronald A |
Controller, CAO |
|
2017-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,148 |
30,052 |
|
- |
|
Ullmann Michael H |
Exec VP, General Counsel |
|
2017-02-13 |
4 |
D |
$115.67 |
$1,225,061 |
D/D |
(10,591) |
110,100 |
|
- |
|
Ullmann Michael H |
Exec VP, General Counsel |
|
2017-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
5,825 |
120,691 |
|
- |
|
1526 Records found
|
|
Page 19 of 62 |
|
|